Wasn't there a strategic review happening? Surely it couldn't take this long and if it was ever finished what were the outcomes? JKahn
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025